Immunoglobulins Running Wild: A Rare Case of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits (PGNMID) Secondary to Waldenstrom Macroglobulinemia (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0757; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "He received 500mg of IV Solumedrol for three days, after which he underwent a kidney biopsy showing a membranoproliferative pattern with IgM and kappa deposits, along with a positive Periodic Acid-Schiff (PAS) stain for pseudothrombi within the capillary loops...He was treated with steroids, bendamustine and plasmapharesis with improvement in his AKI after 10 days to a nadir creatinine of 1.13mg/dL...Anti plasma-cell agents such as daratumumab and bortezomib, along with anti-CD20 agents such as rituximab have proven effective. PGNMID is a novel diagnosis, and more data is needed to understand its pathogenesis and to guide treatment."
Clinical • Acute Kidney Injury • Amyloidosis • Glomerulonephritis • Hematological Disorders • Hematological Malignancies • Lupus Nephritis • Lymphoma • Lymphoplasmacytic Lymphoma • Monoclonal Gammopathy • Nephrology • Renal Disease • Waldenstrom Macroglobulinemia
|
|
Richa Chhaya; Isaac Ely Stillman; Samira S. Farouk; Priya Deshpande
|